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Abstract The m.7510T>C mitochondrial DNA (mtDNA)
mutation is a tRNASer(UCN) alteration leading to matrilineal
isolated hearing impairment. The current paper reviews the
available reports on the m.7510T>C mtDNA mutation,
with special attention to phenotypic variations and hap-
logroup background. A Hungarian family, the fourth family
reported in the literature, is presented, in which analysis of
three generations with bilateral isolated hearing loss
revealed the m.7510T>C tRNASer(UCN) mutation in homo-
plasmic form in the affected members. Haplogroup analysis
verified an unnamed subgroup of mitochondrial haplogroup
H. Previously reported Spanish and North American
Caucasian families belong to different subgroups of
haplogroup H. Analyzing our biobank of Hungarian
patients with sensorineural hearing loss, we did not detect
this mutation in any other patient, nor was it found in
Caucasian haplogroup H control samples. Comparing the
cases reported so far, there is interfamilial variablity in the
age of onset, accompanying symptoms, and haplogroup
background. Our case adds further genetic evidence for the
pathogenicity of the m.7510T>C mutation and underlines
the need to include full mtDNA sequencing in the screening
for unexplained hearing loss.
Introduction
Inherited hearing impairment is among a highly heterogenous
group of disorders (Willems 2000). In the majority of cases it
is non-syndromic, but it can sometimes be associated with
abnormalities of other organ systems as part of a syndrome.
Inherited as a matrilineal trait, sensorineural hearing loss
(SNHL) can be attributed to mtDNA mutations. Isolated,
non-syndromic hearing loss (OMIM #500008) has been
associated classically with mitochondrial 12S rRNA (Prezant
et al. 1993) and tRNASer(UCN) genes (Friedman et al. 1999),
but recent genetic and functional studies suggest the role of
further mitochondrial genes (Zheng et al. 2012), such as the
ND1 of complex I of the respiratory chain (m.3388C>A),
the tRNAIle (m.4295A>G), subunit COII of complex IV
(m.8078G>A), the tRNASer(AGY) (m.12236G>A), the
tRNAHis (m.12201T>C) (Yan et al. 2011), and Cytochrome
B, subunit of complex III (m.15077G>A) (Gutiérrez Cortés
et al. 2012). Certain mutations can cause syndromic or
isolated hearing impairment, as in the m.7445A>G muta-
tion, leading to hearing loss with or without palmoplantar
keratoderma (Reid et al. 1994; Maász et al. 2008), or in the
m.7472insC mutat ion, responsible for hear ing
loss sometimes associated with a neurological disorder
(Verhoeven et al. 1999).
Accumulating data from affected families of different
ethnic backgrounds, and analysis of control cohorts may
gradually confirm the pathogenic role of other rare variants.
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The m.7510T>C alteration in the tRNASer(UCN) was previ-
ously regarded as a rare variant, originally identified in three
large families with matrilineal non-syndromic SNHL
(Hutchin et al. 2000; Castillo et al. 2002; Labay et al.
2008). In the originally reported Caucasian family from the
United Kingdom, the mutation was present in very high
levels of heteroplasmy in blood with no available data on the
haplogroup background (Hutchin et al. 2000). The second
extended Spanish family carried the homoplasmic mutation
on sub-haplogroup H1 (Castillo et al. 2002), while the third
reported family, of North American origin, carried the
mutation on an unnamed subgroup of mitochondrial hap-
logroup H (Labay et al. 2008). The m.7510T>C mtDNA
mutation was not detected in normal Caucasian controls
(Hutchin et al. 2000), nor in haplogroup- or sub-haplogroup-
matched controls (Labay et al. 2008). Although it was not
found in some large screening populations with non-
syndromic SNHL (Jacobs et al. 2005; Lévêque et al. 2007),
several families have already been described.
The current report reviews the available data on the
m.7510T>C mutation with special attention to phenotypic
variations and haplogroup background. Further, a Hungarian
family is presented, the fourth family reported in the literature,
in which the analysis of three generations with bilateral
isolated SNHL revealed the m.7510T>C tRNASer(UCN)
mutation.
Materials and Methods
This study was approved by our Institutional Review
Board. Written informed consent was obtained from all
adults, and parents or legal guardians of all children.
Patients examined at our Department since 2001 with
SNHL served as controls.
Genomic DNAwas prepared from venous blood samples
obtained from three members of the family, the index
patient, his mother, and his maternal grandmother (Fig. 1).
Sequencing for mtDNA mutations was done as described
previously (Maász et al. 2008). The sequences were
compared with the revised Cambridge reference sequence
(http://www.ncbi.nlm.nih.gov/entrez; GenBank: #J01415)
and haplogroup phylogeny from MITOMAP (http://www.
mitomap.org). Heteroplasmy for m.7510T>C was assessed
by HinfI digestion (Fig. 3) (Hutchin et al. 2000; Castillo
et al. 2002).
Patients
Phenotype of the Hungarian family
We examined a four generation Hungarian Caucasian non-
consanguineous family with five affected family members.
The segregation pattern of the hearing loss raised the
possibility of matrilineal inheritance (Fig. 1). Our index
patient (Fig. 1, IV./1.) is a 7-year-old boy with normal
physical appearance, who was born by vaginal delivery at
40 weeks of gestation, weighing 3,200 g. The perinatal
period was uneventful. His early psychomotor development
was age-appropriate: he stood upright at 11 months of age,
walked unaided by 12 months, started to utter words at 16
months and speak fluently at 2 years of age. At the age of
4.5 years he was investigated for hearing loss. At that age it
was noticed that he had coordination problems and a delay
in fine motor skills: he was very clumsy in drawing, he was
unable to stand on one foot and ride the bike and was
uneasy climbing the stairs. Detailed physical and neurolog-
ical examination did not show any alteration apart from his
clumsiness, laboratory investigations were all within the
normal range (repeated lactate and pyruvate levels and
kidney and liver functions were normal), opthalmologic and
cardiologic investigation showed no pathologic finding,
brain MRI and MR angiography as well as EEG were
normal. Conductive hearing loss was ruled out by otoscopic
examination, tympanometry with acoustic reflex testing,
and the use of tuning fork tests. Pure tone audiometry
confirmed bilateral, sensorineural, symmetrical hearing loss
with an average loss of 40 dB HL in both ears (Fig. 4) at
the age of 5 years. His hearing loss showed a slowly
progressive and asymmetrical course, showing an average
of 70 dB HL in the right ear, 80 dB HL in the left ear at the
age of 6 years and 75 dB HL in the right ear and 90 dB HL
in the left ear at the age of 7 years (Fig. 4). The patient
received a hearing aid at the age of 5.5 years. The index
patient has a healthy sister (Fig. 1, IV./2.) 3 years of age, no
signs of hearing loss have been noted in her so far.
Fig. 1 Phenotypic findings of the Hungarian family. Filled symbols
denote the members of the family with non-syndromic hearing
impairment. II/2., III./2., and IV/1. were available for genetic analysis
which showed the m.7510T>C mutation in the tRNASer(UCN) gene of
the mitochondrial DNA. The index patient is indicated by an arrow
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The mother, the maternal grandmother, the maternal
great-aunt and the maternal great-grandmother (Fig. 1) all
developed severe symmetrical isolated sensorineural
hearing loss by the age of 30 years, no audiograms were
available from them. The mother (Fig. 1, III./2.) noticed a
slowly progressive hearing loss in her early 20s, pure tone
audiometry at the age of 30 years confirmed bilateral,
sensorineural, symmetrical hearing loss with an average
loss of 70 dB HL in both ears, she received a hearing-aid in
her late twenties. Both of her pregnancies and especially the
deliveries worsened her hearing deficit. Detailed physical
and neurological examination did not show any other
alteration, laboratory investigations were all within the
normal range (repeated lactate and pyruvate levels and
kidney and liver functions were normal), and opthalmologic
and cardiologic investigation showed no pathologic finding.
The maternal grandmother (Fig. 1, II./2.) and her sister
(Fig. 1, II./3.) also claim to have first noticed their hearing
impairment in their early 20s, no precise information was
available about the maternal great-grandmother. Hearing
loss was slowly progressive in the affected family mem-
bers, no episodes of sudden hearing loss, of worsening of
the symptoms after noise exposure, or episodes of vertigo
were noted, the mother and the maternal grandmother
reported to have intermittent tinnitus.
Genotype of the Hungarian family
The sequence analysis of the patient, his mother, and
grandmother was performed on DNA extracted from blood
leukocytes. No other tissues were available for investiga-
tion. During sequence analysis of the mtDNA in the index
patient, we detected the m.7510T>C mutation in the
tRNASer(UCN) (Fig. 2 all mtDNA sequence variants are
listed in Table 2). We then screened the mother and
maternal grandmother and confirmed the presence of the
mutation in their blood samples. Unfortunately, the great-
aunt and the sister of our index patient were not available
for testing. A specified RFLP assay of all three investigated
1 2 3 4 5
-181
-132
-82
-49
Fig. 3 HinfI PCR-RFLP assay for m.7510T>C heteroplasmy in
the members of the Hungarian SNHL family. Mitochondrial DNA
was PCR amplified and digested with HinfI as described in previous
publications (Hutchin et al. 2000, Castillo et al. 2002). Digestion
product sizes (bp) are shown on the right. Lane 1: Lambda DNA/
EcoRI+HindIII Marker. Lane 2: Wild-type amplification product
containing a single HinfI cleavage site that results in 181 bp and 82 bp
fragments after digestion. Lane 3, 4, and 5: the index patient, his
mother, and his grandmother: the m.7510T>C mutation creates a
HinfI site within the 181 bp fragment that results in 132 bp and 49 bp
products. Since no 181 bp fragment can be detected, all three family
members harbor the mutation in homoplasmic form
7510C
IV/1 affected
control sample
Fig. 2 Electropherograms of the index patient and an unaffected control. Sequence of the index patient and a control. The arrow shows the
mutant 7510C and wild-type 7510T nucleotides of the mitochondrial tRNASer(UCN) gene in the affected proband and a control
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family members confirmed the mutation in homoplasmic
form (Fig. 3).
Haplotype analysis (Herrnstadt et al. 2002) of the index
patient and his family members suggested that the family
carries the mutation on an unnamed subgroup of the
mitochondrial haplogroup H. We assigned the m.7510T>C
mutation containing mitochondrial sequence in our Hungarian
family to haplogroup H, based on the SNP 7028C, which is
specific for all branches of haplogroup H (Herrnstadt et al.
2002). Our sequence contains 4793G, which defines a rare
unnamed sub-haplogroup that is not among the major
subgroups of H (Herrnstadt et al. 2002). In addition, we
excluded the SNPs defining subgroups H1, H2, H3 and H4,
and several other SNPs defining other rare unnamed
subgroups of haplogroup H. We genotyped 60 Caucasian
samples from our SNHL biobank but failed to detect the
m.7510T>C mutation. Only the m.7445A>G mutation and
the m.3243A>G mutations were detected previously
among these samples (Maász et al. 2008). The
m.7510T>C alteration was also absent in 30 Caucasian
haplogroup H healthy controls from our biobank.
In addition, the common deafness associated nuclear
alteration (35delG in the GJB2 gene) was investigated, and
gave negative results in the affected family members.
Phenotype and genotype details of the previously reported
families with the m.7510T>C mutation are listed in Table 1.
Discussion
In this study, we describe a fourth family with matrilineal
transmission of non-syndromic SNHL attributable to the
m.7510T>C transition of the mitochondrial tRNASer(UCN)
gene. Results of previous studies give functional evidence of
an unfavorable effect of m.7510T>C on pre-tRNASer(UCN)
processing (Yan et al. 2006), which may lead to decreased
levels of the mature tRNASer(UCN) overall, thereby limiting
mitochondrial protein synthesis and consequently respiration
as demonstrated for other tRNA mutations (Yarham et al.
2010). One of these studies demonstrated that cells bearing
the tRNASer(UCN) m.7445A>G mutation also have a
decreased synthesis rate of some mitochondrial proteins,
especially the sixth subunit of the NADH dehydrogenase
(ND6), and a significant reduction in the amount of ND6
mRNA (Li et al. 2005). This observation suggests that
the mRNA of the ND6 is derived from the same precursor as
the tRNASer(UCN). The same mechanism may apply for the
m.7510T>C variant, since it also disrupts a highly conserved
base pair in the aminoacyl stem of the tRNASer(UCN)
(Hutchin et al. 2000).
The m.7510T>C mutation has been described in three
families so far (Table 1). In all published families,
symptoms appeared mainly as isolated hearing loss. There
were no reports of cardiac, ophthalmologic, or renal
involvement or movement disorder in the affected family
members (Hutchin et al. 2000; Castillo et al. 2002; Labay
et al. 2008). Our index patient had a delay in fine motor
skills and coordination at the age of 4.5 years when his
hearing loss became evident, but no other organ involve-
ment (renal, cardiac, opthalmologic, endocrine) could be
detected. As accompanying neurological symptoms, epi-
sodes of sudden, severe, and self-limiting vertigo; chronic
or intermittent spontaneous bilateral tinnitus; and worsen-
ing of the symptoms after noise exposure were reported in
the third North American family (Labay et al. 2008).
Penetrance and age of onset of the disease differed within
the pedigrees reported so far (Hutchin et al. 2000; Castillo
et al. 2002; Labay et al. 2008). In the second, Spanish,
family, the largest reported so far, the mutation was
confirmed in 26 members of the family and auditory
impairment was shown in 21 out of 26 carriers. According
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Fig. 4 Air conduction audiograms of the index patient carrying
the m.7510T>C mutation at age 5, 6, and 7 years (y). Squares,
right ear; triangles, left ear. Audiograms of the other affected family
members were not available
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to the symptoms and audiograms, four carriers were
reported to be asymptomatic: at the age of 11, 15, 16, and
31 air conduction audiograms did not reveal an impairment
(Castillo et al. 2002). Although no further data is available
on the asymptomatic carriers, given the intrafamilial
variable onset of the symptoms, it can be speculated that
the carriers did not yet reach the age at which symptoms
would appear. No complete penetrance can be demonstrated
in our Hungarian family either. Although the so far
unaffected, 3-year-old sister of the index patient was not
available for testing, she might be just too young to show
symptoms of hearing loss.
The wide range of age at onset, and the variability among
individuals in the affected families, also suggests that other
mitochondrial or nuclear factors as well as environmental
agents may contribute to the symptoms in these carriers. The
mutation was present in homoplasmic form in the Spanish
and North American family (Castillo et al. 2002; Labay et al.
2008), and also in our Hungarian patients, while it was
reported to be present in a high level of heteroplasmy (>95%
and 90% respectively) in the original UK family (Hutchin
et al. 2000). Only blood leukocytes were available in this
work, and no other tissues were examined in previous
reports. However, the proportion of the normal and the
mutant alleles may vary in the auditory cells, explaining
incomplete penetrance and the difference in the age of onset.
The m.7510T>C mutation has been reported to be a
rare finding and was not found in some large screening
populations with non-syndromic SNHL (Jacobs et al.
2005; Lévêque et al. 2007). It was originally interpreted as
a benign polymorphism defining a deep branch in the
mitochondrial DNA phylogeny (Labay et al. 2008).
However, it was not detected in normal Caucasian
controls (Hutchin et al. 2000), or in haplogroup- and
sub-haplogroup-matched controls (Labay et al. 2008). Our
own investigations demonstrate that it was absent in 60
other Caucasian patients with SNHL and in 30 Caucasian
healthy controls of haplogroup H. Since several families
with isolated SNHL have been described to harbor the
m.7510T>C mutation, it can be regarded as a disease-
causing mutation. Haplotype analysis in our Hungarian
family suggested an unnamed subgroup of haplogroup H,
delineated by the SNP m.4793A>G, which is different
from the haplogroups of the previously reported Spanish
and North American families, and the UK family with a
sequence variant (m.4336A>G) not present in the other
three families. The fact that the m.7510T>C mutation
arose on different mitochondrial subgroups provides
further evidence for the pathogenecity of this mutation.
Evolutionary studies showed that deleterious mitochon-
drial mutations are influenced very strongly by selection
and are eliminated rapidly, so their appearance should be
the result of very recent mutational events and transmitted
through very few generations; thus, founder events are not
likely to be found (Torroni et al. 2003). The finding that
all four so far described families carry the m.7510T>C
mutation on different European mtDNA haplogroup back-
grounds indicates that European haplogroups do not
increase or reduce the risk of expressing the disease
phenotype. Since there is no marked phenotypic variability
among the families, the haplogroup data may support that
phenotypic expression is not necessarily influenced by
haplogroup background.
To our knowledge, this is the fourth family in the
literature with the m.7510T>C tRNASer(UCN) mutation.
Comparing the cases reported so far (Table 1), there is some
variability in the age of onset, the accompanying symptoms
such as tinnitus or increased sensitivity to noise, ototoxicity,
and the haplogroup background. Given the fact that hearing
loss resulting from mitochondrial mutations can exhibit
incomplete penetrance and a broad phenotypic spectrum,
screening for unexplained hearing loss should include full
mtDNA sequencing (encompassing the tRNASer(UCN) muta-
tions) in all cases in which maternal inheritance cannot be
clearly ruled out.
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Synopsis of the Article
We present the fourth family reported in the literature with
bilateral isolated hearing loss due to the m.7510T>C
tRNA Ser(UCN) mutation in an unnamed subgroup of
Table 2 Alterations in the mtDNA sequence of the index patient
mtDNA
variation Category Interpretation
m.709G>A Polymorphism MT-RNR1 (12S rRNA)
m.4769A>G Polymorphism p.Met100Met in MT-ND2
m.4793A>G Polymorphism p.Met92Met in MT-ND2
rare haplogroup H
variant
m.7510T>C Known
mutation
MT-TS1 (tRNA Ser 1)
m.8251G>A Polymorphism p.Gly222Gly in MT-CO2
m.11938C>T Polymorphism p.Leu393Leu in MT-ND4
m.15954A>G Polymorphism MT-NC10 noncoding
Apart from the m.7510T>C mutation, no other pathological alteration
was detected in the index patient
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mitochondrial haplogroup H providing further evidence for
the pathogenic role of the m.7510T>C mitochondrial
mutation.
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